Table of Contents Table of Contents
Previous Page  34 / 172 Next Page
Information
Show Menu
Previous Page 34 / 172 Next Page
Page Background

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

e95

OC.07 UPPER GI

OC.07.1

REFRACTORY PATIENTS WITH NON-ACID REFLUX DISEASE AND

THOSE WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE HAVE

SIMILAR RESPONSE TO ANTI-REFLUX SURGICAL THERAPY

Savarino E.*

2

, Marabotto E.

1

, Furnari M.

1

, Zentilin P.

1

, De Bortoli N.

3

,

Marchi S.

3

, Camerini G.

4

, Savarino V.

1

1

Division of Gastroenterology, Department of Internal Medicine,

University of Genoa, Genoa, Italy,

2

Division of Gastroenterology,

Department of Surgery, Oncology and Gastroenterology, University

of Padua, Padua, Italy,

3

Division of Gastroenterology, Department of

Internal Medicine, University of Pisa, Pisa, Italy,

4

Division of Surgery,

Department of Surgery, University of Genoa, Genoa, Italy

Background and aim:

Recent studies clearly demonstrated the

increased diagnostic yield of impedance-pH monitoring thanks

to its ability to correlate gastro-esophageal reflux disease (GERD)

symptoms with both acid and/or non-acid reflux episodes. However,

data about the clinical usefulness of this additional diagnostic yield

are poor. We aimed to assess whether refractory GERD patients

classified by means of endoscopy and impedance-pH as affected

by non-acid reflux disease (NARD), erosive and non-erosive reflux

disease (ERD and NERD) may equally benefit from anti-reflux

surgery.

Material and methods:

Consecutive patients with persisting

heartburn and/or regurgitation despite 8 weeks of PPI therapy,

were prospectively enrolled in this open label trial. All patients

underwent endoscopy and impedance-pH off-therapy. We measured

esophageal acid exposure time (AET), reflux episodes (acid/non-

acid) and symptom-reflux association. Then, patients with ERD

(endoscopy+), NERD (endoscopy-, AET>4.2% and/or SAP/SI+ for

acid reflux) and NARD (endoscopy-, AET<4.2% and SAP/SI+ for non-

acid reflux or both kind of reflux) underwent laparoscopic Nissen

fundoplication (LNF). Before and at 1, 6 and 12 months after LNF,

reflux symptoms and quality of life were assessed using validated

questionnaires. Endoscopy and impedance–pH was repeated 1 year

after surgery. Surgical treatment failure was considered in case

of: persisting typical reflux symptoms and/or objective evidence

of GERD (esophagitis at upper endoscopy, abnormal AET and/or

number of refluxes, positive symptom association) and/or poor

quality of life.

Results:

Out of sixty-five refractory patients, forty-eight (24F/24M;

mean age 49; 14 ERD, 22 NERD and 12 NARD) were included. At 1

year follow-up, LNF had similar pathophysiological effects in all

groups. Indeed, percentage of patients with abnormal AET (ERD 93%

vs 7%, NERD 71% vs 0%) and/or increased number of reflux episodes

(ERD 93% vs 0%, NERD 86% vs 0%, NARD 83% vs. 0%), mean AET (ERD

12.9% vs 1.8%, NERD 6.1% vs 0.7, NARD 0.7% vs 0.4%) and median

number of total (ERD 100 vs 6, NERD 73 vs 9, NARD 72 vs 10), acid

and non-acid refluxes significantly decreased (in all cases, p<0.01).

As to the surgical outcome, the percentage of patients with resolved

or markedly improved typical symptoms at 12 months after LNF was

similar among groups (ERD 93% vs. NERD 82% vs NARD 83%, p=ns).

Quality of life similarly improved in all groups (p=ns). Finally, the

percentage of failure and/or adverse events did not differ among the

groups (ERD 21% vs. NERD 23% vs NARD 17%, p=ns).

Conclusions:

Our data show that LNF was a safe and effective

procedure in relieving typical reflux symptoms in PPI-refractory

patients identified as affected by ERD, NERD and NARD, by means of

endoscopy and impedance-pH monitoring. Therefore, impedance-

pH testing allowed a more clear identification of refractory patients

whose symptoms are related to reflux, thus improving their

management and outcome.

OC.07.2

FUNCTIONAL HEARTBURN OVERLAPS WITH IRRITABLE BOWEL

SYNDROME MORE OFTEN THAN GERD. DEVELOPMENT OF

PREDICTIVE MODELS WITH NOMOGRAMS

De Bortoli N.*

1

, Frazzoni L.

2

, Savarino E.V.

3

, Martinucci I.

1

,

Frazzoni M.

4

, Tolone S.

5

, Marabotto E.

6

, Furnari M.

6

, Bodini G.

6

,

Fuccio L.

2

, Bellini M.

1

, Savarino V.

6

, Marchi S.

1

1

University of Pisa, Pisa, Italy,

2

University of Bologna, Bologna, Italy,

3

University of Padua, Padua, Italy,

4

Baggiovara Hospital, Modena,

Italy,

5

Second University of Naples, Naples, Italy,

6

University of Genoa,

Genoa, Italy

Background and aim:

Gastroesophageal reflux disease (GERD)

and irritable bowel syndrome (IBS) are gastrointestinal disorders

affecting a large part of the general population, with relevant impact

on quality of life and health care costs. We aimed to evaluate the

prevalence of irritable bowel syndrome (IBS) in patients with reflux

symptoms as distinguished into gastroesophageal reflux disease

(GERD) and functional heartburn (FH) on the basis of multichannel

intraluminal impedance (MII)-pH monitoring. We also aimed to

develop a predictive model for FH.

Material and methods:

Patients underwent a structured interview

based on questionnaires for GERD, IBS, anxiety and depression. Upper

GI endoscopy and 24h MII-pH monitoring were performed in all cases.

In patients with IBS, fecal calprotectin was measured and colonoscopy

was scheduled for values >100 mg/Kg to exclude organic disease.

Multivariate logistic regression analysis was performed to identify

independent risk factors for FH and to develop predictive models.

Results:

Of the 701 patients with heartburn who entered the study,

458 (65%) had GERD whereas 243 (35%) had FH. IBS was found in

143/458 (31%) GERD but in 187/243 (77%) FH patients (P <0.001). At

multivariate analysis IBS, anxiety, and smoking resulted independent

risk factors for FH whereas hiatal hernia resulted protective. Two

predictive models, based on clinical only (ISAC) or clinical and

endoscopic characteristics (ISAA-HH) were developed: the area

under the ROC curve did not differ between ISAC (0.861, 95% CI

0.833-0.890) and ISAA-HH (0.872, 95%CI 0.844-0.899) (P =0.110).

Fig. 1.

Nomogram derived from the ISAA-HH (IBS, Smoking, Anxiety, Age, Hiatal hernia,

H. pylori positivity) predictivemodel. Each independent variable corresponds to an axis;

in order to obtain the corresponding score, the position on the axis must be reported

perpendicularly on the “Points axis” at the top of the figure (e.g., anxiety diagnosis

corresponds to 100 points). This passage has to be repeated for all the variables. Then,

the total predictive score is obtained by summing all the single scores, and must be

reported on the “Total points” axis. The position has to be perpendicularly reported on

the “Predicted FH probability” axis to obtain the predicted probability of FH diagnosis.